We have advised the sole shareholder of SkinClinic, a firm specialising in skin care cosmetics, on its sale to Nexxus Iberia, a private equity fund focused on the mid-market segment.
Founded in 2002 and based in Alicante, SkinClinic has established itself as a leading player in the Spanish market for advanced professional cosmetics and personal care. It offers a wide range of high-quality facial and body treatments, renowned for the innovation of its formulas. The company employs more than 90 professionals and has a strong presence in aesthetic medicine clinics and dermatological practices, serving more than 3,000 professional clients throughout the country. It also engages in third-party manufacturing and sells directly to consumers through its online shop.
Its founder and owner, Cayetano Gutiérrez, has led the company for more than two decades, driven by a clear entrepreneurial vision and a firm commitment to growth. Having achieved his strategic objectives, he turned to Clearwater to identify an investment partner to support the company’s next phase. Leveraging our deep sector expertise, we designed and implemented a tailor-made solution in partnership with José Luis García-Pons and Nexxus Iberia, creating the optimal framework for the company’s next stage of growth. García-Pons will assume the role of CEO, bringing extensive experience in the cosmetics and nutritional supplements sectors.
Headquartered in Madrid and founded in 2016, Nexxus Iberia manages over €240m through its second fund, focusing on high-growth mid-market companies in the Iberian Peninsula, particularly in the health, wellness, services, and specialised consumer sectors.
This transaction represents a strategic alliance between Cayetano Gutiérrez, Nexxus Iberia, and the new management team, aimed at accelerating SkinClinic’s national and international expansion while enhancing its organisational and management capabilities.
